about
Computational analyses of synergism in small molecular network motifsAn Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.Amylin activates distributed CNS nuclei to control energy balance.Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.Combinatorial code governing cellular responses to complex stimuli.Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats.Synergy: a concept in search of a definition.Nonsteroidal anti-inflammatory drugs modulate cellular glycosaminoglycan synthesis by affecting EGFR and PI3K signaling pathwaysAnalysis of drug combinations: current methodological landscape.Intestinal GLP-1 and satiation: from man to rodents and back.The actions of drug combinations on the GABAA receptor manifest as curvilinear isoboles of additivity.Combination therapy for the treatment of pulmonary mold infections.Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Evaluation of antiviral drug synergy in an infectious HCV system.Unlocking the Potential of High-Throughput Drug Combination Assays Using Acoustic Dispensing.Theory of synergistic effects: Hill-type response surfaces as 'null-interaction' models for mixtures.Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry.A golden approach to ion channel inhibitionTumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell linesCombinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.Suppressive drug combinations and their potential to combat antibiotic resistance.A SYSTEMATIC APPROACH FOR ASSESSING, IN THE ABSENCE OF FULL EVIDENCE, WHETHER MULTICOMPONENT INTERVENTIONS CAN BE MORE COST-EFFECTIVE THAN SINGLE COMPONENT INTERVENTIONS.When the Whole is Not Greater than the Sum of the Parts: A Critical Review of Laboratory Bioassay Effects Testing for Insecticidal Protein Interactions.Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition.Harnessing synthetic lethality to predict the response to cancer treatment.A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer
P2860
Q28541174-ADC5A963-5411-4E71-9497-8969EBDA7561Q33580906-3706502F-4DBF-42E9-9C7E-3DFB8E3B7891Q33962500-71CC837C-6BAF-4AF7-AF9A-513C437C8533Q34788066-95FD53FD-8A3B-476C-B96E-F333316D24FFQ35541099-505A9920-2A54-4E41-9A03-730909F343D5Q36254618-5D272154-24E1-4AD6-92E3-90765150F022Q36260304-BC401B82-85C1-42ED-A674-7F168F89E3A0Q37240176-EE60FA9F-E1E8-405A-AF6B-FDBF85E76163Q37667936-2072F3B7-1972-460F-96DC-73C73826EE19Q38546567-B14B0319-4D2D-4CA4-94CE-EF1FC42BCEB2Q38575560-6D6A47F6-9136-4944-B975-85694F088A1BQ38633275-75D8AF9A-0A7D-4F18-88CE-7998FFF2FEB7Q38806932-B7B7CCF1-FACB-42D2-95BB-38E893C79698Q38916167-7BDEEFCB-1667-492C-B33B-ECC5F0B8C55AQ39047697-67904B1B-7848-4DF6-B577-37279A42E975Q39871877-195984EB-4BFF-4EEC-8682-7EDDC47E2367Q40752102-BD9F6E0A-B643-499A-8277-11B2CA065D44Q41226219-4EC8E97A-7472-4881-B4B0-AF0FCF5F0B39Q41612750-F525BA2F-B55A-4F9D-ABE6-115075A973FDQ42140961-EC421CE8-D791-4223-B014-DE0C0ABE7ED3Q42292362-CB366A00-19FC-4B9D-A405-4B41762C2D5DQ42322248-4A2F85E3-EAE2-407C-8F74-91E980364CD1Q42612662-EDE67AD2-5BC1-4200-BF94-97A56202EF2CQ47702493-4FB7E1D0-372E-4DC4-AA0A-60EEB36609F0Q50061559-13BA58FE-5483-49C9-8AEA-C1717E37295AQ50268907-A1735895-C8A2-4EB7-A453-E81C47F2F2D6Q55384044-5A65E2AA-A538-4E35-B30F-6186509C3482Q58740657-E2A48B95-140C-418E-9989-1A3C1B1B4EFF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding synergy.
@en
type
label
Understanding synergy.
@en
prefLabel
Understanding synergy.
@en
P2860
P1476
Understanding synergy.
@en
P2093
Nori Geary
P2860
P304
P356
10.1152/AJPENDO.00308.2012
P577
2012-12-04T00:00:00Z